These results suggest that the DNA alkylating agent, dHBD, was effectively delivered to JIMT-1 tumor cells by the anti-B7-H3 monoclonal antibody, leading to apoptotic cell death following DNA damage and S phase arrest. The gene discussed is CD276; the disease is neoplasm.